New drug could slow the development of Alzheimer's

"Compound 10" is how Ursula Quitterer refers to the chemical compound that her team has developed and that could slow the progression of Alzheimer's disease.

Quitterer is a professor of molecular pharmacology at ETH Zurich and has so far tested the active ingredient first in mice, revealing promising effects: The typical death of nerve cells seen in dementia is significantly slower, and the animals survive longer. ...